1 year return (CAGR)
276.90%
Spero Therapeutics Inc Exchange (NASDAQ, USD)
SPRO
1.11
-0.03 (-1.20%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
12.75%
5 year return (CAGR)
-29.30%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
143.60M
Price/Sales
2.41
Ent value
113.23M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
16.75
PEG
-
Forward P/E
3.26
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.54 |
| Daily high | 2.63 |
| Daily low | 2.48 |
| Daily Volume | 464K |
| All-time high | 22.07 |
| 1y analyst estimate | 4.00 |
| Beta | 1.48 |
| EPS (TTM) | 0.13 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| SPRO | S&P500 | |
| Current price drop from All-time high | -94.97% | -3.06% |
| Highest price drop | -97.46% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -61.99% | -10.68% |
| Avg time to new high | 112 days | 12 days |
| Max time to new high | 1342 days | 1805 days |
News
